1.  Background opioids/naloxone. Details of intra-nasal and IM naloxone
  2. Groups who should receive it with opioids – the “recommend” and “consider”
  3. How these groups apply at WI Sleep – i.e. patients co-prescribed BZDs, SDB patients, etc.
  4. Some of our numbers at WI sleep
  5. Implementation and application strategies
Session date: 
04/24/2019 - 12:15pm to 1:15pm CDT
Wisconsin Sleep HERI Classroom 165
6001 Research Park Blvd
MAdison , WI 53719
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
John Dopp, Pharm D